The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BOLD-100-001 (TRIO039): A phase Ib dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid tumors.
 
Grainne M. O'Kane
Honoraria - Eisai; Roche
Consulting or Advisory Role - Eisai; Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Jennifer L. Spratlin
Honoraria - Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Celgene; Eisai; Lilly/ImClone; Sanofi; Taiho Pharmaceutical
Research Funding - Celgene (Inst); Sanofi
Travel, Accommodations, Expenses - Astellas Pharma
 
Petr Kavan
Stock and Other Ownership Interests - Bristol-Myers Squibb; Teva
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical
Research Funding - Amgen (Inst)
 
Rachel Anne Goodwin
Honoraria - Celgene; Eisai; Ipsen; Merck; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Celgene; Eisai; Ipsen; Merck; Novartis; Pfizer; SERVIER
Speakers' Bureau - Eisai; Ipsen
Research Funding - Ipsen
 
Elaine McWhirter
Consulting or Advisory Role - BMSi; EMD Serono; Merck; Novartis
 
Darby Thompson
No Relationships to Disclose
 
Michelle Jones
Employment - Bold Therapeutics
Stock and Other Ownership Interests - Arbutus Biopharma
Consulting or Advisory Role - Symvivo
 
Edward Russell McAllister
Employment - Bold Therapeutics; Intezyne Technologies
Leadership - Bold Therapeutics; Intezyne Technologies
Stock and Other Ownership Interests - Bold Therapeutics; Intezyne Technologies
 
Andres Machado
No Relationships to Disclose
 
Yasmin Lemmerick
Research Funding - Bold Therapeutics
 
Leticia Wilson
No Relationships to Disclose
 
Jim Pankovich
Employment - Bold Therapeutics
Leadership - Bold Therapeutics
Stock and Other Ownership Interests - Bold Therapeutics
Consulting or Advisory Role - Qu Biologics
Patents, Royalties, Other Intellectual Property - Bold Therapeutics